Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: next letter

The next letter will probably clarify alittle more what the JV with NuPower will bring. May advise that PTSC is considering purchasing full ownership of the Nupower IP after the validation period.... maybe the letter is advise that PTSC has completed their validation period and going full steam with the NuPower Joint venture and annoucing plans to include TPL for the licensing...



well see.. good stuff.... nothing sexy or flashy.. but a solid step in the right direction. Up and to the Right hahaha had to put that one in there......

Share
New Message
Please login to post a reply